Specifically, the inactivation of SRSF1 in tumor cells leads to a reduction in glycolytic metabolism and results in a marked increase in the number of tumor-infiltrating CD8+ T cells, along with a decrease in regulatory T cells (Tregs) within the TME. This evidence concerns the gene CD8A and neoplasm.